About
Innate Pharma (NASDAQ:IPHA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Innate Pharma to Participate in the D. Boral Capital Global Conference
Apr 17 2026
Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026
Apr 13 2026
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026
Apr 8 2026
Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event
Apr 3 2026
Innate Pharma to Participate in the Kempen Life Sciences Conference
Financials
Revenue
$9.01 M
Market Cap
$133.22 M
EPS
-0.64
Translate